You are here: Home » Current Affairs » News » National
Business Standard

Indian-American cardiologist invests $60 million in medical device company

The investment by the Indian American cardiologist will pave way for clinical studies

Press Trust of India  |  Houston 

Pharmaceuticals, drugs, pharma industry, medical, health, lab
Representative Image

An Indian-American cardiologist and entrepreneur has invested $60 million in a medical company that will support clinical trial on to replace stent.

Dr Kiran Patel's investment is for the Inc, a Florida-based medical device company's (IDE) for the world's first sirolimus-coated balloon.

is a drug-coated balloon, which is a replacement of the stent. If a stent cannot be placed in human body or doesn't have a good outcome, then sirolimus balloon is used.

According to the company, the investment by the will pave way for to reduce risk of heart blockages.

Patel's investment will pay for on coated with a substance that reduces the risk of heart blockages and the length of time a patient needs to take blood thinners, according to a statement issued by the company.

Noting that cardiovascular diseases represents 31 per cent of all global deaths, Patel said that his contribution will help towards the healthcare of millions of people around the world.

"I am excited to be a part of CMI whose research & innovative technologies will meet a major unmet need in patients with diabetes and cardiovascular diseases. This venture enables me to contribute to the millions of hearts beating around the world," Patel was quoted as saying in the release.

A portion of the funds will also be utilised to bolster the manufacturing operations to meet the increasing demand for their products globally.

First Published: Fri, October 12 2018. 10:35 IST